表紙：羊膜の世界市場－機会分析および業界予測：製品別、アプリケーション別、エンドユーザー別（2021年～2030年）

市場調査レポート

商品コード

1070525

羊膜の世界市場－機会分析および業界予測：製品別、アプリケーション別、エンドユーザー別（2021年～2030年）

Amniotic Membrane Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

出版日: 2022年03月07日 | 発行: Allied Market Research

| ページ情報: 英文 201 Pages | 納期: 2～3営業日

価格

PDF (Single User License)

USD 5,769 898,579円

レポートPDFを1つのPCでご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は1回だけ可能です。印刷したレポートの利用もPDFのライセンス保持者になります。回覧のための複製も原則NGです。

PDF (5-user License)

USD 6,929 1,079,261円

レポートPDFを5名でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFの保存、表示、利用が可能です。PDF内のテキスト等のコピー＆ペーストは可能です。PDFの印刷は5回可能です。印刷したレポートの利用もPDFのライセンス保持者5名となります。

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

USD 10,663 1,660,868円

レポートPDFとExcel定量データをひとつの企業、及びその子会社でご利用頂けるライセンスです。ライセンスを付与されたPCでのみレポートPDFとExcelの保存、表示、利用が可能です。PDFとExcel内のテキスト等のコピー＆ペーストは可能です。PDFとExcelの印刷回数の制限はありません。印刷したレポートの利用は企業、及びその子会社内にて共有可能です。無料でレポートのアップデートがご利用いただけます。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=155.76円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の羊膜の市場規模は、2020年の11億245万米ドルから2030年には17億2,805万米ドルに達し、予測期間中に4.6%のCAGRで成長すると予想されています。

世界の羊膜市場の成長を牽引する主な要因としては、羊膜移植の増加、羊膜移植の利点に関する認知度や教育の向上が挙げられます。しかし、医療従事者の不足が市場の成長を抑制しています。

当レポートでは、世界の羊膜市場について調査分析し、市場情勢、市場分析、企業プロファイルなど、体系的な情報を提供しています。

市場の定義と範囲
主な調査結果
- 主な投資ポケット
- 主な成功戦略
ポーターのファイブフォース分析
- 供給企業の交渉力
- 新規参入業者の脅威
- 代替品の脅威
- 競争企業間の敵対関係
- バイヤー間の交渉力
市場シェア分析/主要企業のポジショニング
- 市場シェア分析/主要企業のポジショニング（2020年）
市場力学
- 促進要因
- 抑制要因
- 市場機会
COVID-19影響分析

第4章羊膜市場：製品タイプ別

市場概要
市場規模と予測：製品タイプ別
凍結保存羊膜
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
凍結乾燥羊膜
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別

第5章羊膜市場：アプリケーション別

市場概要
市場規模と予測：アプリケーション別
外科的創傷
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
眼科
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
その他
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別

第6章羊膜市場：エンドユーザー別

市場概要
市場規模と予測：エンドユーザー別
病院
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
外来手術センター
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
専門クリニック
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別
研究センターと研究所
- 主要な市場動向、成長因子および機会
- 市場規模と予測：地域別
- 市場シェア分析：国別

第7章羊膜市場：地域別

市場概要
市場規模と予測：地域別
北米
- 主要な市場動向と機会
- 市場規模と予測：製品タイプ別
- 市場規模と予測：アプリケーション別
- 市場規模と予測：エンドユーザー別
- 市場規模と予測：国別
- 米国の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- カナダの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- メキシコの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
欧州
- 主要な市場動向と機会
- 市場規模と予測：製品タイプ別
- 市場規模と予測：アプリケーション別
- 市場規模と予測：エンドユーザー別
- 市場規模と予測：国別
- ドイツの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- フランスの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- 英国の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- イタリアの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- スペインの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- その他の欧州の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
アジア太平洋
- 主要な市場動向と機会
- 市場規模と予測：製品タイプ別
- 市場規模と予測：アプリケーション別
- 市場規模と予測：エンドユーザー別
- 市場規模と予測：国別
- 日本の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- 中国の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- オーストラリアの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- インドの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- 韓国の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- その他のアジア太平洋の羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
ラテンアメリカ・中東・アフリカ
- 主要な市場動向と機会
- 市場規模と予測：製品タイプ別
- 市場規模と予測：アプリケーション別
- 市場規模と予測：エンドユーザー別
- 市場規模と予測：国別
- ブラジルの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- 南アフリカの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- サウジアラビアの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別
- その他のラテンアメリカ・中東・アフリカの羊膜市場
  - 市場規模と予測：製品タイプ別
  - 市場規模と予測：アプリケーション別
  - 市場規模と予測：エンドユーザー別

第8章企業プロファイル

Allosure, Inc
Amnio Technology, LLC
Applied Biologics LLC
FzioMed Inc
Human Regenerative Technologies, LLC
Integra Lifesciences Holdings Corporation
Katena, Inc.
MiMedx Group Inc
Skye Biologics Inc
Tissue-Tech Inc

図表

LIST OF TABLES

TABLE 1.GLOBAL AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 2.GLOBAL AMNIOTIC MEMBRANE MARKET FOR CRYOPRESERVED AMNIOTIC MEMBRANE, BY REGION, 2020-2030 ($MILLION)
TABLE 3.GLOBAL AMNIOTIC MEMBRANE MARKET FOR LYOPHILIZATION AMNIOTIC MEMBRANE, BY REGION, 2020-2030 ($MILLION)
TABLE 4.GLOBAL AMNIOTIC MEMBRANE MARKET, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 5.GLOBAL AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUND, BY REGION, 2020-2030 ($MILLION)
TABLE 6.GLOBAL AMNIOTIC MEMBRANE MARKET FOR OPTHALOMOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 7.GLOBAL AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 8.GLOBAL AMNIOTIC MEMBRANE MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 9.GLOBAL AMNIOTIC MEMBRANE MARKET FOR HOSPITAL, BY REGION, 2020-2030 ($MILLION)
TABLE 10.GLOBAL AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2020-2030 ($MILLION)
TABLE 11.GLOBAL AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 12.GLOBAL AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTER AND LABS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.GLOBAL AMNIOTIC MEMBRANE MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 14.NORTH AMERICA AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
TABLE 15.NORTH AMERICA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 16.NORTH AMERICA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 17.NORTH AMERICA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 18.U.S. AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 19.U.S. AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 20.U.S. AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 21.CANADA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 22.CANADA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 23.CANADA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 24.MEXICO AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 25.MEXICO AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 26.MEXICO AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 27.EUROPE AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
TABLE 28.EUROPE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 29.EUROPE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 30.EUROPE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 31.GERMANY AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 32.GERMANY AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 33.GERMANY AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 34.FRANCE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 35.FRANCE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 36.FRANCE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 37.UK AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 38.UK AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 39.UK AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 40.ITALY AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 41.ITALY AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 42.ITALY AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 43.SPAIN AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 44.SPAIN AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 45.SPAIN AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 46.REST OF EUROPE AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 47.REST OF EUROPE AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 48.REST OF EUROPE AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 49.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
TABLE 50.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 51.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 52.ASIA-PACIFIC AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 53.JAPAN AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 54.JAPAN AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 55.JAPAN AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 56.CHINA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 57.CHINA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 58.CHINA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 59.AUSTRALIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 60.AUSTRALIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 61.AUSTRALIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 62.INDIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 63.INDIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 64.INDIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 65.SOUTH KOREA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 66.SOUTH KOREA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 67.SOUTH KOREA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 68.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 69.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 70.REST OF ASIA PACIFIC AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 71.LAMEA AMNIOTIC MEMBRANE, BY Region, 2020-2030 ($MILLION)
TABLE 72.LAMEA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 73.LAMEA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 74.LAMEA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 75.BRAZIL AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 76.BRAZIL AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 77.BRAZIL AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 78.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 79.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 80.SOUTH AFRICA, AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 81.SAUDI ARABIA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 82.SAUDI ARABIA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 83.SAUDI ARABIA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 84.REST OF LAMEA AMNIOTIC MEMBRANE, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 85.REST OF LAMEA AMNIOTIC MEMBRANE, BY APPLICATION, 2020-2030 ($MILLION)
TABLE 86.REST OF LAMEA AMNIOTIC MEMBRANE, BY END USER, 2020-2030 ($MILLION)
TABLE 87.ALLOSURE, INC INC: KEY EXECUTIVES
TABLE 88.ALLOSURE, INC INC: COMPANY SNAPSHOT
TABLE 89.ALLOSURE, INC INC: OPERATING SEGMENTS
TABLE 90.ALLOSURE, INC INC: PRODUCT PORTFOLIO
TABLE 91.ALLOSURE, INC INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 92.AMNIO TECHNOLOGY, LLC: KEY EXECUTIVES
TABLE 93.AMNIO TECHNOLOGY, LLC: COMPANY SNAPSHOT
TABLE 94.AMNIO TECHNOLOGY, LLC: OPERATING SEGMENTS
TABLE 95.AMNIO TECHNOLOGY, LLC: PRODUCT PORTFOLIO
TABLE 96.AMNIO TECHNOLOGY, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97.APPLIED BIOLOGICS LLC: KEY EXECUTIVES
TABLE 98.APPLIED BIOLOGICS LLC: COMPANY SNAPSHOT
TABLE 99.APPLIED BIOLOGICS LLC: OPERATING SEGMENTS
TABLE 100.APPLIED BIOLOGICS LLC: PRODUCT PORTFOLIO
TABLE 101.APPLIED BIOLOGICS LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 102.FZIOMED INC: KEY EXECUTIVES
TABLE 103.FZIOMED INC: COMPANY SNAPSHOT
TABLE 104.FZIOMED INC: OPERATING SEGMENTS
TABLE 105.FZIOMED INC: PRODUCT PORTFOLIO
TABLE 106.FZIOMED INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.HUMAN REGENERATIVE TECHNOLOGIES, LLC: KEY EXECUTIVES
TABLE 108.HUMAN REGENERATIVE TECHNOLOGIES, LLC: COMPANY SNAPSHOT
TABLE 109.HUMAN REGENERATIVE TECHNOLOGIES, LLC: OPERATING SEGMENTS
TABLE 110.HUMAN REGENERATIVE TECHNOLOGIES, LLC: PRODUCT PORTFOLIO
TABLE 111.HUMAN REGENERATIVE TECHNOLOGIES, LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 112.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY EXECUTIVES
TABLE 113.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT
TABLE 114.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: OPERATING SEGMENTS
TABLE 115.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT PORTFOLIO
TABLE 116.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 117.KATENA, INC.: KEY EXECUTIVES
TABLE 118.KATENA, INC.: COMPANY SNAPSHOT
TABLE 119.KATENA, INC.: OPERATING SEGMENTS
TABLE 120.KATENA, INC.: PRODUCT PORTFOLIO
TABLE 121.KATENA, INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 122.MIMEDX GROUP INC: KEY EXECUTIVES
TABLE 123.MIMEDX GROUP INC: COMPANY SNAPSHOT
TABLE 124.MIMEDX GROUP INC: OPERATING SEGMENTS
TABLE 125.MIMEDX GROUP INC: PRODUCT PORTFOLIO
TABLE 126.MIMEDX GROUP INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 127.SKYE BIOLOGICS INC: KEY EXECUTIVES
TABLE 128.SKYE BIOLOGICS INC: COMPANY SNAPSHOT
TABLE 129.SKYE BIOLOGICS INC: OPERATING SEGMENTS
TABLE 130.SKYE BIOLOGICS INC: PRODUCT PORTFOLIO
TABLE 131.SKYE BIOLOGICS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132.TISSUE-TECH INC: KEY EXECUTIVES
TABLE 133.TISSUE-TECH INC: COMPANY SNAPSHOT
TABLE 134.TISSUE-TECH INC: OPERATING SEGMENTS
TABLE 135.TISSUE-TECH INC: PRODUCT PORTFOLIO
TABLE 136.TISSUE-TECH INC: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 1.GLOBAL AMNIOTIC MEMBRANE MARKET SEGMENTATION
FIGURE 2.GLOBAL AMNIOTIC MEMBRANE MARKET
FIGURE 3.SEGMENTATION AMNIOTIC MEMBRANE MARKET
FIGURE 4.TOP INVESTMENT POCKET IN AMNIOTIC MEMBRANE MARKET
FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
FIGURE 11.LOW THREAT OF SUBSTITUTION
FIGURE 12.HIGH COMPETITIVE RIVALRY
FIGURE 13.TOP PLAYER POSITIONING, 2020
FIGURE 14.MARKET SHARE ANALYSIS, 2020
FIGURE 15.RESTRAINTS AND DRIVERS: AMNIOTIC MEMBRANE MARKET
FIGURE 16.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY PRODUCT TYPE
FIGURE 17.AMNIOTIC MEMBRANE MARKET FOR CRYOPRESERVED AMNIOTIC MEMBRANE, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 18.AMNIOTIC MEMBRANE MARKET FOR LYOPHILIZATION AMNIOTIC MEMBRANE, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 19.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY APPLICATION
FIGURE 20.AMNIOTIC MEMBRANE MARKET FOR SURGICAL WOUND, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 21.AMNIOTIC MEMBRANE MARKET FOR OPTHALOMOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 22.AMNIOTIC MEMBRANE MARKET FOR OTHERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 23.AMNIOTIC MEMBRANE MARKET SEGMENTATION, BY END USER
FIGURE 24.AMNIOTIC MEMBRANE MARKET FOR HOSPITAL, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 25.AMNIOTIC MEMBRANE MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 26.AMNIOTIC MEMBRANE MARKET FOR SPECIALIZED CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 27.AMNIOTIC MEMBRANE MARKET FOR RESEARCH CENTER AND LABS, BY COUNTRY, 2020-2030 ($MILLION)
FIGURE 28.ALLOSURE, INC INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 29.ALLOSURE, INC INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 30.ALLOSURE, INC INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 31.AMNIO TECHNOLOGY, LLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 32.AMNIO TECHNOLOGY, LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 33.AMNIO TECHNOLOGY, LLC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 34.APPLIED BIOLOGICS LLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 35.APPLIED BIOLOGICS LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 36.APPLIED BIOLOGICS LLC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 37.FZIOMED INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 38.FZIOMED INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 39.FZIOMED INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 40.HUMAN REGENERATIVE TECHNOLOGIES, LLC: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.HUMAN REGENERATIVE TECHNOLOGIES, LLC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 42.HUMAN REGENERATIVE TECHNOLOGIES, LLC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 43.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: NET SALES, 2018-2020 ($MILLION)
FIGURE 44.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.INTEGRA LIFESCIENCES HOLDINGS CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.KATENA, INC.: NET SALES, 2018-2020 ($MILLION)
FIGURE 47.KATENA, INC.: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 48.KATENA, INC.: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 49.MIMEDX GROUP INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 50.MIMEDX GROUP INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 51.MIMEDX GROUP INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 52.SKYE BIOLOGICS INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 53.SKYE BIOLOGICS INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 54.SKYE BIOLOGICS INC: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 55.TISSUE-TECH INC: NET SALES, 2018-2020 ($MILLION)
FIGURE 56.TISSUE-TECH INC: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 57.TISSUE-TECH INC: REVENUE SHARE, BY REGION, 2020 (%)

Product Code: LI_184559 / A04208

The global amniotic membrane market was valued at $1,102.45 million in 2020 and is projected to reach $1,728.05 million by 2030, registering a CAGR of 4.6% from 2021 to 2030.

Amniotic membrane is the inmost layer of the placenta, which includes a thick basement membrane or a tissue and an avascular stromal matrix. This membrane has the ability to promote healing; thus, it is utilized in surgical procedures related to Genito-urinary tract, skin, brain, and head and neck. In addition, amniotic membrane is increasingly used for ocular surface reconstruction, including the treatment of persistent epithelial defects and non-healing corneal ulcers, corneal perforations and descemetoceles, bullous keratopathy, as well as corneal disorders with associated limbal stem cell deficiency.

The major factors that drive the growth of the global amniotic membrane market include rise in amniotic membrane transplantation and rise in awareness and education about the benefits of amniotic membrane transplantation. In addition, technological innovations to develop cost-effective therapies are expected to lead to a paradigm shift in the amniotic membrane market globally. However, lack of healthcare professionals restricts the market growth.

The global amniotic membrane market is segmented on the basis of type of product, application, end user and region. According to product type, the market is divided into cryopreserved amniotic membrane and lyophilization amniotic membrane. On the basis of applications, the market is divided into surgical wounds, ophthalmology, and others. On the basis of end user, the market is divided into hospitals, ambulatory surgical centers, specialized clinics, and research center & laboratories. Regionally, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA).

The major companies profiled in the report include AlloSure, Inc., Amnio Technology, LLC, Applied Biologics LLC, FzioMed, Inc., Human Regenerative Technologies, LLC, Integra Lifesciences Holdings Corporation, Corza Ophthalmology, MiMedx Group, Inc, Skye Biologics Inc., and TissueTech, Inc.

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the global amniotic membrane market, with current trends and future estimations to elucidate the imminent investment pockets.
Comprehensive analysis of factors that drive and restrict the market growth is provided detailed quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.
Extensive analysis of the key segments of the industry helps understand the type of products and applications used globally.
Key players and their strategies are provided to understand the competitive outlook of the market.

By Product
Cryopreserved Amniotic Membrane
Lyophilization Amniotic Membrane

By Application
- Surgical Wounds
- Ophthalmology
- Others
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialized Clinics
- Research Centers & laboratories
By Region
- North America
  - U.S.
  - Canada
  - Mexico
- Europe
  - Germany
  - France
  - UK
  - Italy
  - Spain
  - Rest of Europe
- Asia-Pacific
  - China
  - Japan
  - India
  - Australia
  - South Korea
  - Rest of Asia-Pacific
- LAMEA
  - Brazil
  - Saudi Arabia
  - South Africa
  - Rest of LAMEA
KEY Players
- Allosure, Inc.
- Amnio Technology, LLC
- Applied Biologics LLC
- FzioMed, Inc.
- Human Regenerative Technologies, LLC
- Integra Lifesciences Holdings Corporation
- Corza Ophthalmology
- MiMedx Group, Inc.
- Skye Biologics Inc.
- TissueTech, Inc.

CHAPTER 1:INTRODUCTION

1.1.Report Description
1.2.Key Market Segments
1.3.Key Benefits
1.4.Research Methodology
- 1.4.1. Primary Research
- 1.4.2. Secondary Research
- 1.4.3. Analyst Tools and Models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.CXO Perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market Definition and Scope
3.2.Key Findings
- 3.2.1. Top Investment Pockets
- 3.2.2. Top Winning Strategies
3.3.Porter's Five Forces Analysis
- 3.3.1. Bargaining Power of Suppliers
- 3.3.2. Threat of New Entrants
- 3.3.3. Threat of Substitutes
- 3.3.4. Competitive Rivalry
- 3.3.5. Bargaining Power among Buyers
3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
3.6.COVID-19 Impact Analysis

CHAPTER 4:AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE

4.1.Market Overview
4.1.1Market Size and Forecast, By Product Type
4.2.Cryopreserved Amniotic Membrane
- 4.2.1. Key Market Trends, Growth Factors and Opportunities
- 4.2.2. Market Size and Forecast, By Region
- 4.2.3. Market Share Analysis, By Country
4.3.Lyophilization Amniotic Membrane
- 4.3.1. Key Market Trends, Growth Factors and Opportunities
- 4.3.2. Market Size and Forecast, By Region
- 4.3.3. Market Share Analysis, By Country

CHAPTER 5:AMNIOTIC MEMBRANE MARKET, BY APPLICATION

5.1.Market Overview
5.1.1Market Size and Forecast, By Application
5.2.Surgical Wound
- 5.2.1. Key Market Trends, Growth Factors and Opportunities
- 5.2.2. Market Size and Forecast, By Region
- 5.2.3. Market Share Analysis, By Country
5.3.Opthalomology
- 5.3.1. Key Market Trends, Growth Factors and Opportunities
- 5.3.2. Market Size and Forecast, By Region
- 5.3.3. Market Share Analysis, By Country
5.4.Others
- 5.4.1. Key Market Trends, Growth Factors and Opportunities
- 5.4.2. Market Size and Forecast, By Region
- 5.4.3. Market Share Analysis, By Country

CHAPTER 6:AMNIOTIC MEMBRANE MARKET, BY END USER

6.1.Market Overview
6.1.1Market Size and Forecast, By End User
6.2.Hospital
- 6.2.1. Key Market Trends, Growth Factors and Opportunities
- 6.2.2. Market Size and Forecast, By Region
- 6.2.3. Market Share Analysis, By Country
6.3.Ambulatory Surgical Centers
- 6.3.1. Key Market Trends, Growth Factors and Opportunities
- 6.3.2. Market Size and Forecast, By Region
- 6.3.3. Market Share Analysis, By Country
6.4.Specialized Clinics
- 6.4.1. Key Market Trends, Growth Factors and Opportunities
- 6.4.2. Market Size and Forecast, By Region
- 6.4.3. Market Share Analysis, By Country
6.5.Research Center And Labs
- 6.5.1. Key Market Trends, Growth Factors and Opportunities
- 6.5.2. Market Size and Forecast, By Region
- 6.5.3. Market Share Analysis, By Country

CHAPTER 7:AMNIOTIC MEMBRANE MARKET, BY REGION

7.1.Market Overview
7.1.1Market Size and Forecast, By Region
7.2.North America
- 7.2.1. Key Market Trends and Opportunities
- 7.2.2. Market Size and Forecast, By Product Type
- 7.2.3. Market Size and Forecast, By Application
- 7.2.4. Market Size and Forecast, By End User
- 7.2.5. Market Size and Forecast, By Country
- 7.2.6. U.s. Amniotic Membrane Market
  - 7.2.6.1. Market Size and Forecast, By Product Type
  - 7.2.6.2. Market Size and Forecast, By Application
  - 7.2.6.3. Market Size and Forecast, By End User
- 7.2.7. Canada Amniotic Membrane Market
  - 7.2.7.1. Market Size and Forecast, By Product Type
  - 7.2.7.2. Market Size and Forecast, By Application
  - 7.2.7.3. Market Size and Forecast, By End User
- 7.2.8. Mexico Amniotic Membrane Market
  - 7.2.8.1. Market Size and Forecast, By Product Type
  - 7.2.8.2. Market Size and Forecast, By Application
  - 7.2.8.3. Market Size and Forecast, By End User
7.3.Europe
- 7.3.1. Key Market Trends and Opportunities
- 7.3.2. Market Size and Forecast, By Product Type
- 7.3.3. Market Size and Forecast, By Application
- 7.3.4. Market Size and Forecast, By End User
- 7.3.5. Market Size and Forecast, By Country
- 7.3.6. Germany Amniotic Membrane Market
  - 7.3.6.1. Market Size and Forecast, By Product Type
  - 7.3.6.2. Market Size and Forecast, By Application
  - 7.3.6.3. Market Size and Forecast, By End User
- 7.3.7. France Amniotic Membrane Market
  - 7.3.7.1. Market Size and Forecast, By Product Type
  - 7.3.7.2. Market Size and Forecast, By Application
  - 7.3.7.3. Market Size and Forecast, By End User
- 7.3.8. Uk Amniotic Membrane Market
  - 7.3.8.1. Market Size and Forecast, By Product Type
  - 7.3.8.2. Market Size and Forecast, By Application
  - 7.3.8.3. Market Size and Forecast, By End User
- 7.3.9. Italy Amniotic Membrane Market
  - 7.3.9.1. Market Size and Forecast, By Product Type
  - 7.3.9.2. Market Size and Forecast, By Application
  - 7.3.9.3. Market Size and Forecast, By End User
- 7.3.10. Spain Amniotic Membrane Market
  - 7.3.10.1. Market Size and Forecast, By Product Type
  - 7.3.10.2. Market Size and Forecast, By Application
  - 7.3.10.3. Market Size and Forecast, By End User
- 7.3.11. Rest Of Europe Amniotic Membrane Market
  - 7.3.11.1. Market Size and Forecast, By Product Type
  - 7.3.11.2. Market Size and Forecast, By Application
  - 7.3.11.3. Market Size and Forecast, By End User
7.4.Asia-Pacific
- 7.4.1. Key Market Trends and Opportunities
- 7.4.2. Market Size and Forecast, By Product Type
- 7.4.3. Market Size and Forecast, By Application
- 7.4.4. Market Size and Forecast, By End User
- 7.4.5. Market Size and Forecast, By Country
- 7.4.6. Japan Amniotic Membrane Market
  - 7.4.6.1. Market Size and Forecast, By Product Type
  - 7.4.6.2. Market Size and Forecast, By Application
  - 7.4.6.3. Market Size and Forecast, By End User
- 7.4.7. China Amniotic Membrane Market
  - 7.4.7.1. Market Size and Forecast, By Product Type
  - 7.4.7.2. Market Size and Forecast, By Application
  - 7.4.7.3. Market Size and Forecast, By End User
- 7.4.8. Australia Amniotic Membrane Market
  - 7.4.8.1. Market Size and Forecast, By Product Type
  - 7.4.8.2. Market Size and Forecast, By Application
  - 7.4.8.3. Market Size and Forecast, By End User
- 7.4.9. India Amniotic Membrane Market
  - 7.4.9.1. Market Size and Forecast, By Product Type
  - 7.4.9.2. Market Size and Forecast, By Application
  - 7.4.9.3. Market Size and Forecast, By End User
- 7.4.10. South Korea Amniotic Membrane Market
  - 7.4.10.1. Market Size and Forecast, By Product Type
  - 7.4.10.2. Market Size and Forecast, By Application
  - 7.4.10.3. Market Size and Forecast, By End User
- 7.4.11. Rest of Asia Pacific Amniotic Membrane Market
  - 7.4.11.1. Market Size and Forecast, By Product Type
  - 7.4.11.2. Market Size and Forecast, By Application
  - 7.4.11.3. Market Size and Forecast, By End User
7.5.LAMEA
- 7.5.1. Key Market Trends and Opportunities
- 7.5.2. Market Size and Forecast, By Product Type
- 7.5.3. Market Size and Forecast, By Application
- 7.5.4. Market Size and Forecast, By End User
- 7.5.5. Market Size and Forecast, By Country
- 7.5.6. Brazil Amniotic Membrane Market
  - 7.5.6.1. Market Size and Forecast, By Product Type
  - 7.5.6.2. Market Size and Forecast, By Application
  - 7.5.6.3. Market Size and Forecast, By End User
- 7.5.7. South Africa, Amniotic Membrane Market
  - 7.5.7.1. Market Size and Forecast, By Product Type
  - 7.5.7.2. Market Size and Forecast, By Application
  - 7.5.7.3. Market Size and Forecast, By End User
- 7.5.8. Saudi Arabia Amniotic Membrane Market
  - 7.5.8.1. Market Size and Forecast, By Product Type
  - 7.5.8.2. Market Size and Forecast, By Application
  - 7.5.8.3. Market Size and Forecast, By End User
- 7.5.9. Rest of LAMEA Amniotic Membrane Market
  - 7.5.9.1. Market Size and Forecast, By Product Type
  - 7.5.9.2. Market Size and Forecast, By Application
  - 7.5.9.3. Market Size and Forecast, By End User

CHAPTER 8:COMPANY PROFILES

8.1.Allosure, Inc
- 8.1.1.Company Overview
- 8.1.2.Key Executives
- 8.1.3.Company snapshot
- 8.1.4.Operating business segments
- 8.1.5.Product portfolio
- 8.1.6.Business Performance
- 8.1.7.Key Strategic Moves and Developments
8.2.Amnio Technology, LLC
- 8.2.1.Company Overview
- 8.2.2.Key Executives
- 8.2.3.Company snapshot
- 8.2.4.Operating business segments
- 8.2.5.Product portfolio
- 8.2.6.Business Performance
- 8.2.7.Key Strategic Moves and Developments
8.3.Applied Biologics LLC
- 8.3.1.Company Overview
- 8.3.2.Key Executives
- 8.3.3.Company snapshot
- 8.3.4.Operating business segments
- 8.3.5.Product portfolio
- 8.3.6.Business Performance
- 8.3.7.Key Strategic Moves and Developments
8.4.FzioMed Inc
- 8.4.1.Company Overview
- 8.4.2.Key Executives
- 8.4.3.Company snapshot
- 8.4.4.Operating business segments
- 8.4.5.Product portfolio
- 8.4.6.Business Performance
- 8.4.7.Key Strategic Moves and Developments
8.5.Human Regenerative Technologies, LLC
- 8.5.1.Company Overview
- 8.5.2.Key Executives
- 8.5.3.Company snapshot
- 8.5.4.Operating business segments
- 8.5.5.Product portfolio
- 8.5.6.Business Performance
- 8.5.7.Key Strategic Moves and Developments
8.6.Integra Lifesciences Holdings Corporation
- 8.6.1.Company Overview
- 8.6.2.Key Executives
- 8.6.3.Company snapshot
- 8.6.4.Operating business segments
- 8.6.5.Product portfolio
- 8.6.6.Business Performance
- 8.6.7.Key Strategic Moves and Developments
8.7.Katena, Inc.
- 8.7.1.Company Overview
- 8.7.2.Key Executives
- 8.7.3.Company snapshot
- 8.7.4.Operating business segments
- 8.7.5.Product portfolio
- 8.7.6.Business Performance
- 8.7.7.Key Strategic Moves and Developments
8.8.MiMedx Group Inc
- 8.8.1.Company Overview
- 8.8.2.Key Executives
- 8.8.3.Company snapshot
- 8.8.4.Operating business segments
- 8.8.5.Product portfolio
- 8.8.6.Business Performance
- 8.8.7.Key Strategic Moves and Developments
8.9.Skye Biologics Inc
- 8.9.1.Company Overview
- 8.9.2.Key Executives
- 8.9.3.Company snapshot
- 8.9.4.Operating business segments
- 8.9.5.Product portfolio
- 8.9.6.Business Performance
- 8.9.7.Key Strategic Moves and Developments
8.10.Tissue-Tech Inc
- 8.10.1.Company Overview
- 8.10.2.Key Executives
- 8.10.3.Company snapshot
- 8.10.4.Operating business segments
- 8.10.5.Product portfolio
- 8.10.6.Business Performance
- 8.10.7.Key Strategic Moves and Developments

羊膜の世界市場－機会分析および業界予測：製品別、アプリケーション別、エンドユーザー別（2021年～2030年）

Amniotic Membrane Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場情勢

第4章羊膜市場：製品タイプ別

第5章羊膜市場：アプリケーション別

第6章羊膜市場：エンドユーザー別

第7章羊膜市場：地域別

第8章企業プロファイル

LIST OF TABLES

LIST OF FIGURES

KEY BENEFITS FOR STAKEHOLDERS

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET LANDSCAPE

CHAPTER 4:AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE

CHAPTER 5:AMNIOTIC MEMBRANE MARKET, BY APPLICATION

CHAPTER 6:AMNIOTIC MEMBRANE MARKET, BY END USER

CHAPTER 7:AMNIOTIC MEMBRANE MARKET, BY REGION

CHAPTER 8:COMPANY PROFILES

羊膜の世界市場－機会分析および業界予測：製品別、アプリケーション別、エンドユーザー別（2021年～2030年）

Amniotic Membrane Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2021-2030

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場情勢

第4章 羊膜市場：製品タイプ別

第5章 羊膜市場：アプリケーション別

第6章 羊膜市場：エンドユーザー別

第7章 羊膜市場：地域別

第8章 企業プロファイル

LIST OF TABLES

LIST OF FIGURES

KEY BENEFITS FOR STAKEHOLDERS

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

CHAPTER 2:EXECUTIVE SUMMARY

CHAPTER 3:MARKET LANDSCAPE

CHAPTER 4:AMNIOTIC MEMBRANE MARKET, BY PRODUCT TYPE

CHAPTER 5:AMNIOTIC MEMBRANE MARKET, BY APPLICATION

CHAPTER 6:AMNIOTIC MEMBRANE MARKET, BY END USER

CHAPTER 7:AMNIOTIC MEMBRANE MARKET, BY REGION

CHAPTER 8:COMPANY PROFILES

第1章イントロダクション

第2章エグゼクティブサマリー

第3章市場情勢

第4章羊膜市場：製品タイプ別

第5章羊膜市場：アプリケーション別

第6章羊膜市場：エンドユーザー別

第7章羊膜市場：地域別

第8章企業プロファイル